• SENSEX
    NIFTY 50
Market

CNBCTV18's top stocks to watch out for on November 11

Updated : 2019-11-11 07:55:41

Indian shares are likely to open little changed on Monday on the back of muted global trades and amid concerns of slowing economic growth. Asian shares traded marginally higher after positive statements from US over the weekend about trade talks with China. However, uncertainties around the final deal capped gans. The SGX Nifty futures traded at 13.5 points, or 0.11 percent lower at 11,933.50, indicating a flat start for the Sensex and the Nifty50.

Maruti Suzuki: MSI reduced its production by 20.7 percent in October, making it the ninth straight month when the country's largest carmaker lowered its output. The company produced a total of 1,19,337 units in October as against 1,50,497 units in the year-ago month. In September, the automaker had cut its production by 17.48 per cent to 1,32,199 units. (Image: Reuters)
Maruti Suzuki: MSI reduced its production by 20.7 percent in October, making it the ninth straight month when the country's largest carmaker lowered its output. The company produced a total of 1,19,337 units in October as against 1,50,497 units in the year-ago month. In September, the automaker had cut its production by 17.48 per cent to 1,32,199 units. (Image: Reuters)
Glenmark Pharmaceuticals: Glenmark is recalling close to 2.17 lakh cartons of Estradiol Vaginal inserts in the US market due to faulty delivery system, as per a report by the USFDA. The company's US-based arm is recalling the lots of the product used for providing relief from menopause symptom.. (Image: Company)
Glenmark Pharmaceuticals: Glenmark is recalling close to 2.17 lakh cartons of Estradiol Vaginal inserts in the US market due to faulty delivery system, as per a report by the USFDA. The company's US-based arm is recalling the lots of the product used for providing relief from menopause symptom.. (Image: Company)
Bank of Baroda: Q2 net profit jumped 394.63 percent to Rs 737 crore due to higher net interest income. Net interest income (NII) grew at 10.1 percent to Rs 7,028 crore. Net interest margin improved by 19 basis points to 2.81 percent in Q2 FY20. Gross NPA ratio was at 10.25 percent and net NPA was 3.91 percent. (Image: Reuters)
Bank of Baroda: Q2 net profit jumped 394.63 percent to Rs 737 crore due to higher net interest income. Net interest income (NII) grew at 10.1 percent to Rs 7,028 crore. Net interest margin improved by 19 basis points to 2.81 percent in Q2 FY20. Gross NPA ratio was at 10.25 percent and net NPA was 3.91 percent. (Image: Reuters)
Laurus Labs: The company said it has received two observations from the USFDA for its FDF and API Integrated Facility, Unit 2 at Visakhapatnam. It said these observations are procedural in nature. This is a product pre-approval audit by USFDA, and no data integrity issues were observed in the inspection. The inspection was carried out from 04 November 2019 – 08 November 2019. (Stock Image)
Laurus Labs: The company said it has received two observations from the USFDA for its FDF and API Integrated Facility, Unit 2 at Visakhapatnam. It said these observations are procedural in nature. This is a product pre-approval audit by USFDA, and no data integrity issues were observed in the inspection. The inspection was carried out from 04 November 2019 – 08 November 2019. (Stock Image)
Aurobindo Pharma: The firm said the news about the company’s buyout of Sandoz assets being delayed on FTC query is factually incorrect. “We are pleased to report that we are making good progress in working with the Federal Trade Commission (FTC) as part of the customary merger clearance process,” it said. (Image: Company)
Aurobindo Pharma: The firm said the news about the company’s buyout of Sandoz assets being delayed on FTC query is factually incorrect. “We are pleased to report that we are making good progress in working with the Federal Trade Commission (FTC) as part of the customary merger clearance process,” it said. (Image: Company)
Lupin: It received USFDA approval for Zileulon extended-release tablets to market generic equivalent of Zyflo CR for treatment of asthma. The tablets, 600 mg, are indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. The drug had annual sales of approximately USD 43 million in the US, according to IQVIA MAT September 2019. (Image: Company)
Lupin: It received USFDA approval for Zileulon extended-release tablets to market generic equivalent of Zyflo CR for treatment of asthma. The tablets, 600 mg, are indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. The drug had annual sales of approximately USD 43 million in the US, according to IQVIA MAT September 2019. (Image: Company)
JSW Steel: India Ratings has reaffirmed long-term issuer rating to
JSW Steel: India Ratings has reaffirmed long-term issuer rating to "IND AA" for NCD program of JSW Steel. The outlook on the long-term rating has been revised to Negative from Stable. The Outlook revision reflects Ind-Ra's view of fall in per tonne margins and its impact on JSWSL's credit profile in FY20. (Image: Reuters)
TTK Prestige: The company has completed expansions at its Tamil Nadu and Gujarat facilities for manufacturing of stainless-steel pressure cookers/kitchenware. The commercial production at the facilities has commenced. (Image: Company)
TTK Prestige: The company has completed expansions at its Tamil Nadu and Gujarat facilities for manufacturing of stainless-steel pressure cookers/kitchenware. The commercial production at the facilities has commenced. (Image: Company)
Shree Renuka Sugars: The company reported a consolidated net profit of Rs 2,739.6 crore for the second quarter ended September 30, compared to a net loss of Rs 432.7 crore in the year-ago quarter. (Stock Image)
Shree Renuka Sugars: The company reported a consolidated net profit of Rs 2,739.6 crore for the second quarter ended September 30, compared to a net loss of Rs 432.7 crore in the year-ago quarter. (Stock Image)
DLF: The realty major’s sales bookings rose 16 percent to Rs 1,425 crore during the first six months of this fiscal year, mainly due to demand for its ready-to-move-in residential units. DLF had achieved sales bookings of Rs 1,225 crore in the same period a year ago. (Image: Company)
DLF: The realty major’s sales bookings rose 16 percent to Rs 1,425 crore during the first six months of this fiscal year, mainly due to demand for its ready-to-move-in residential units. DLF had achieved sales bookings of Rs 1,225 crore in the same period a year ago. (Image: Company)
Affle India: Q2 consolidated profit after tax rose 51 percent to Rs 155.88 crore. Total income during the quarter increased by around 42 percent to Rs 853.54 crore. Affle stocks were listed on Indian stock exchanges in July this year. (Image: Company)
Affle India: Q2 consolidated profit after tax rose 51 percent to Rs 155.88 crore. Total income during the quarter increased by around 42 percent to Rs 853.54 crore. Affle stocks were listed on Indian stock exchanges in July this year. (Image: Company)
NTPC: Q2 net profit rose 38 percent to Rs 3,409 crore. Total income rose to Rs 26,274.66 crore in the quarter from Rs 23,566.65 crore a year ago. The company's average tariff during the first half of this fiscal was Rs 3.74 per unit. The gross power generation dipped to 61.64 billion units (BU) in the quarter from 65.98 BU year ago. Similarly, the gross power generation also dropped to 130.14 BU from 153.20 BU a year ago. (Image: Company)
NTPC: Q2 net profit rose 38 percent to Rs 3,409 crore. Total income rose to Rs 26,274.66 crore in the quarter from Rs 23,566.65 crore a year ago. The company's average tariff during the first half of this fiscal was Rs 3.74 per unit. The gross power generation dipped to 61.64 billion units (BU) in the quarter from 65.98 BU year ago. Similarly, the gross power generation also dropped to 130.14 BU from 153.20 BU a year ago. (Image: Company)
Lakshmi Vilas Bank: Q2 net loss widened to Rs 357 crore from Rs 132.31 crore in the July-September of 2018-19. Total income of the bank also fell to Rs 665.33 crore during the quarter as compared to Rs 800.50 crore a year ago. Interest income was down at Rs 607.33 crore, as against Rs 729.29 crore a year ago.
Lakshmi Vilas Bank: Q2 net loss widened to Rs 357 crore from Rs 132.31 crore in the July-September of 2018-19. Total income of the bank also fell to Rs 665.33 crore during the quarter as compared to Rs 800.50 crore a year ago. Interest income was down at Rs 607.33 crore, as against Rs 729.29 crore a year ago.
Ashok Leyland: Q2 net profit declined 93 percent to Rs 39 crore. The Hinduja Group flagship’s revenue stood at Rs 3,929 crore for the quarter, down 48 percent from Rs 7,621 crore in the year-ago period. (Image: Company)
Ashok Leyland: Q2 net profit declined 93 percent to Rs 39 crore. The Hinduja Group flagship’s revenue stood at Rs 3,929 crore for the quarter, down 48 percent from Rs 7,621 crore in the year-ago period. (Image: Company)
Live TV

Ask Our Experts CNBC TV18